Maxim Group Rates Braiin (BRAI) buy, $10 Price Target
Maxim Group maintains its buy rating on BRAI with a $10 price target, a 30.89% upside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
Maxim Group rated Braiin Limited ($BRAI) "buy" with a $10 price target on June 15, 2026.
Since the rating, $BRAI is up 2.9% after 1 week, down 23.0% after 1 month and down 40.7% to date (from the $7.35 close on Jun 15, 2026).
BRAI
Braiin Limited
Key Points
- Maxim Group analyst Allen Klee reiterated a buy rating for BRAI on June 15, 2026, setting a price target of $10.
- Maxim Group's $10 price target implies 30.89% upside from Braiin Limited's ($BRAI) current $7.64 share price.
- Shares of BRAI are trading at $7.64, with no exchange information provided.
- Morgan Stanley and Royal Bank of Canada are among institutional investors holding shares in BRAI.
Get $BRAI trade alerts by text
We text you when insiders, Congress or big funds trade $BRAI. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Braiin Limited alert may contain errors. Disclosures
Maxim Group analyst Allen Klee has reiterated a buy rating for BRAI, maintaining a price target of $10. This reaffirmation came on June 15, 2026, as the stock traded at $7.64.
Other Institutional Activity in BRAI
Morgan Stanley grew its holdings by 2,400 shares, ending with 2,400 shares worth about $16,704. Similarly, Royal Bank of Canada added 495 shares, bringing its total to 495 shares valued at approximately $3,000. Tower Research Capital LLC (TRC) also made a small addition, increasing its position by 3 shares to hold 3 shares worth $21.
Analysts Set New Price Targets
On June 15, 2026, Maxim Group reiterated its buy rating on BRAI, setting a price target of $10. This reflects the firm's positive outlook on the stock.
About BRAI
Details about BRAI's operations, sector, or industry were not provided in the fundamentals data. However, the company continues to attract attention from analysts and institutional investors.
Bottom Line
Maxim Group's reaffirmation of a buy rating with a $10 target highlights continued confidence in BRAI. While the current trading price is $7.64, the reiterated target suggests potential upside. Institutional investors like Morgan Stanley and Royal Bank of Canada are also maintaining positions in the company.
$BRAI price target
Braiin Limited daily closes and this analyst's $10 target. Not advice.
Related Filing Alerts
Source: Maxim Group's rating change on $BRAI (Jun 15, 2026). Written by software, not financial advice. How we make alerts